SEC Filing | Larimar Therapeutics, Inc.
Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selection | British Journal of Cancer
Study design with overlapping SAD-MAD cohorts, where treatment periods... | Download Scientific Diagram
CR Tidbit – SAD MAD Studies | AuroBlog | Clinical Research Blog | Aurous HealthCare CRO, India
Regulus Therapeutics Advances to Cohort 3 of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Frontiers | Molecular Signatures of Response to Mecasermin in Children With Rett Syndrome
Types of Study in Early Clinical Development - EUPATI Toolbox
Quantitative Decision Making (QDM) in Phase I/II studies - ppt download
Levels of Ethical Review
Clinical Considerations for First-in-Human (FIH) and Early Phase Clinical Trials | Simbec-Orion
Adaptive and Innovative Study Designs to Accelerate Drug Development from First-In-Human to First-In-Patient
Clinical development: present and future | Basicmedical Key
Safety, tolerability of ES16001, a novel varicella zoster virus reactivation inhibitor, in healthy adults | European Journal of Medical Research | Full Text
First in human dose - clinical trial designs.pptx
Study design. Subjects in SAD cohort 4, part 2, were dosed in the fed... | Download Scientific Diagram
EX-99.1
Accelerating development with combined SAD/MAD approach
SEC Filing | Alkermes plc
On Biostatistics and Clinical Trials: November 2017
A Randomized Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of the Novel Myostatin Inhibitor Apitegromab (SRK-015): A Potential Treatment for Spinal Muscular Atrophy | Advances in Therapy
STATISTICAL ANALYSIS PLAN Protocol PQ-010-001 PHASE 1B, RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED, DOSE ESCALATION STUDY TO
Illustrative 'accelerated' development 'go/no-go' plan of an add-on... | Download Scientific Diagram
MAD Cohorts 1 to 4: Participants receiving ECC5004 for Type 2 Diabetes Clinical Trial 2024 | Power
Types of Study in Early Clinical Development - EUPATI Toolbox
